BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35576337)

  • 1. Association of Pharmacist Prescription of Contraception With Breaks in Coverage.
    Rodriguez MI; Manibusan B; Kaufman M; McConnell KJ
    Obstet Gynecol; 2022 May; 139(5):781-787. PubMed ID: 35576337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical contraindications to combined hormonal contraceptive use among women using methods prescribed by a pharmacist.
    Rodriguez MI; Kaufman M; Manibusan B; Anderson L; McConnell KJ
    Contraception; 2021 Nov; 104(5):547-552. PubMed ID: 34116068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Pharmacist Prescription With Dispensed Duration of Hormonal Contraception.
    Rodriguez MI; Edelman AB; Skye M; Anderson L; Darney BG
    JAMA Netw Open; 2020 May; 3(5):e205252. PubMed ID: 32432710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of pharmacist prescription and 12-month contraceptive continuation rates.
    Rodriguez MI; Skye M; Edelman AB; Anderson L; Darney BG
    Am J Obstet Gynecol; 2021 Dec; 225(6):647.e1-647.e9. PubMed ID: 34217725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacist Provision of Hormonal Contraception in the Oregon Medicaid Population.
    Anderson L; Hartung DM; Middleton L; Rodriguez MI
    Obstet Gynecol; 2019 Jun; 133(6):1231-1237. PubMed ID: 31135739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist prescription and access to hormonal contraception for Medicaid-insured women in Oregon.
    Gibbs SE; Harvey SM
    Contraception; 2020 Oct; 102(4):262-266. PubMed ID: 32652093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Pharmacist Prescription of Hormonal Contraception With Unintended Pregnancies and Medicaid Costs.
    Rodriguez MI; Hersh A; Anderson LB; Hartung DM; Edelman AB
    Obstet Gynecol; 2019 Jun; 133(6):1238-1246. PubMed ID: 31135740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists expand access to reproductive heaLthcare: PEARL study protocol.
    Rodriguez MI; Darney BG; Edelman AB; Yee K; Anderson LB; McConnell KJ
    BMC Health Serv Res; 2019 Apr; 19(1):207. PubMed ID: 30935394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Oregon's 12-Month Contraceptive Supply Policy and Quantity of Contraceptives Dispensed.
    Rodriguez MI; Lin SC; Steenland M; McConnell KJ
    JAMA Health Forum; 2022 Feb; 3(2):e215146. PubMed ID: 35977278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing pharmacist and clinician perspectives on pharmacist-prescribed hormonal contraceptives.
    Whalen A; Bratberg J; Cohen L; Orr K; Lemay V
    J Am Pharm Assoc (2003); 2024; 64(1):314-320.e3. PubMed ID: 37967721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in contraceptive use according to HIV status among privately insured women in the United States.
    Haddad LB; Monsour M; Tepper NK; Whiteman MK; Kourtis AP; Jamieson DJ
    Am J Obstet Gynecol; 2017 Dec; 217(6):676.e1-676.e11. PubMed ID: 28866122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing pharmacist-prescribed hormonal contraception services and users in California and Oregon pharmacies.
    Lu S; Rafie S; Hamper J; Strauss R; Kroon L
    Contraception; 2019 Apr; 99(4):239-243. PubMed ID: 30562478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. North Carolina Pharmacists' Support for Hormonal Contraception Prescription Status Change.
    Parry RA; Seamon G; Scott MA; Tak CR
    J Pharm Pract; 2023 Aug; 36(4):769-776. PubMed ID: 35325584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real world outcomes related to providing an annual supply of short-acting hormonal contraceptives.
    Niu F; Cornelius J; Aboubechara N; Saraj A; Lurvey L; Tran-Pugh A; Le K; Hui RL
    Contraception; 2022 Mar; 107():58-61. PubMed ID: 34742717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of a pharmacist-led hormonal contraceptive prescribing service in a campus community pharmacy in Indiana, United States.
    Ahmad ZM; Noel NL; Rudd TM; Nadelson CS; Ott MA; Wilkinson TA; Meredith AH
    Contraception; 2022 Sep; 113():113-118. PubMed ID: 35577148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community perspectives on pharmacist-prescribed hormonal contraception in rural California.
    Gomez AM; Rafie S; Garner-Ford E; Arcara J; Arteaga S; Britter M; De La Cruz M; Gleaton SK; Gomez-Vidal C; Luna B; Ortiz C; Rivera MC; Schuman L; Watanabe M; Logan R
    Contraception; 2022 Oct; 114():10-17. PubMed ID: 35671841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
    Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
    Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twelve-month prescribing of contraceptive pill, patch, and ring before and after a standardized electronic medical record order change.
    Uhm S; Chen MJ; Cutler ED; Creinin MD
    Contraception; 2021 Jan; 103(1):60-63. PubMed ID: 33098853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to hormonal contraception among women veterans: differences by race/ethnicity and contraceptive supply.
    Borrero S; Zhao X; Mor MK; Schwarz EB; Good CB; Gellad WF
    Am J Obstet Gynecol; 2013 Aug; 209(2):103.e1-11. PubMed ID: 23524170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacist prescription of hormonal contraception in Oregon: Baseline knowledge and interest in provision.
    Rodriguez MI; McConnell KJ; Swartz J; Edelman AB
    J Am Pharm Assoc (2003); 2016; 56(5):521-6. PubMed ID: 27594105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.